← Investments

Portfolio company

HISHOH Biopharma㈱

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Digital Health

About

The company develops next-generation allergen immunotherapies to treat patients suffering from allergic rhinitis, asthma, atopic dermatitis and food allergies.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies